Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × acalabrutinib × 1 year × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 44 Lymphoma, Mantle-Cell 23 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, Non-Hodgkin 9 Lymphoma 9 Lymphoma, B-Cell 5 Waldenstrom Macroglobulinemia 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, B-Cell 4 Leukemia 3 Multiple Myeloma 2 Lymphoproliferative Disorders 2 Lymphatic Diseases 2 Leukemia, Prolymphocytic 2 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Part1: Advanced B-cell Malignancies 1 Neuritis 1 Neoplasms 1 Neoplasm, Residual 1 Leukemia, Hairy Cell 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Hematologic Diseases 1 Heart Failure 1 Glioblastoma 1 Chromosome 17 deletion 1 Cardiovascular Diseases 1 Burkitt Lymphoma 1

Interventions

pembrolizumab 44 Gemcitabine 23 enfortumab vedotin 19 Nivolumab 19 Cisplatin 17 avelumab 16 Magnetic Resonance Spectroscopy 15 atezolizumab 14 Carboplatin 14 Docetaxel 12 Specimen Handling 11 sacituzumab govitecan 8 Paclitaxel 8 Ipilimumab 8 durvalumab 6 Fluorodeoxyglucose F18 5 cabozantinib 4 Taxes 4 toripalimab 3 pemigatinib 3 erdafitinib 3 X-Rays 3 Radiosurgery 3 Platinum 3 Pemetrexed 3 Mitomycin 3 Immunoglobulin G 3 CTLA-4 Antigen 3 Biopsy 3 ALT-803 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡